Patient education: Managing pulmonary oedema

Patient education: Managing pulmonary oedema

            The treatment of pulmonary oedema requires an understanding of the medical history of a patient and their lifestyle. The condition can be caused by environmental, dietary choices, or genetic factors. In this instance, the replacement of potassium and the increase in oxygen supply will play a crucial role in managing this condition. The patient can achieve positive treatment outcomes through the provision of managed care and the use of evidence-based intervention strategies.

Patient assessment    

The 75-year-old female patient weighs 157Ib and has a BMI of 23.9. The patient is suffering from Pulmonary Edema. Furthermore, the patient also has atrial fibrillation and fluid overload. As such, effective intervention measures are required to protect the patient from suffering long-term harm or death.

The patient is experiencing heart palpitations and is reliant on the atrial fibrillation on the telemetry monitor—the vitals BP 106/60 pulse 134 highlights the necessity for immediate treatment. The patient has also indicated that she experiences shortness of pain, which may point to more significant respiratory problems. In this situation, it is evident that she requires admission to a healthcare facility. Moreover, it is correct that the patient requires both lifestyle and behavioral changes to eliminate the underlying causes.

Causes of the condition

Acute oedema has a high mortality, a factor that notes the importance of early treatment in the management of this disease. The significance of this problem is that Pulmonary oedema is typically caused by a diverse range of factors that must be addressed during the treatment process (Purvey & Allen, 2017). The condition may be caused by myocardial ischemia and atrial fibrillation. As such, the treatment processes must start with the identification of the cause. Besides, the caregivers must review the medicines to determine if some of them had contributed towards the worsening of the condition.

Interventions

The patient will be admitted into a healthcare facility to ensure she gets evidence-based care and round the clock nursing care. According to Chioncel et al. (2015), reestablishing tissue regeneration is critical to the recovery of pulmonary oedema patients. As such, together with the stabilization of the patient’s thermodynamic condition, these are the primary interventions in the provision of managed care. Reestablishing tissue regeneration and maintaining information about the caregiver will seek to maintain sufficient blood pressure that will be used in the perfusion of vital organs. However, the long-term success of this initiative requires caregivers to address the underlying causes (Purvey & Allen, 2017). The management of this condition requires a multi-pronged intervention measure aimed at eliminating the underlying root causes. Besides, non-adherence to the treatment regime suggested by a caregiver and adverse drug effects can result in the re-occurrence of the disease.

The second intervention strategy involves the replacement of potassium. The approach must be implemented gradually to increase compliance among patients. The lifestyle change is essential in enhancing the health and well-being of a patient. The monitoring of consumption habits is essential because it contributes to the improvement of long-term outcomes. However, the patient must take an active role in facilitating their recovery.

Conclusion

In sum, the management of pulmonary oedema requires behavioral and lifestyle changes. Despite the advanced age of the patient, there is an opportunity for overcoming the disease through increasing oxygen flow in her body and the replacement of potassium. In light of the lack of sufficient evidence to support the provision of evidence-based care, caregivers need to enlist the active participation of the patient and her family members in the management of care.

References

Chioncel, O., Collins, S. P., Ambrosy, A. P., Gheorghiade, M., & Filippatos, G. (2015). Pulmonary Oedema-Therapeutic Targets. Cardiac failure review, 1(1), 38–45. https://doi.org/10.15420/CFR.2015.01.01.38

Purvey, M., & Allen, G. (2017). Managing acute pulmonary oedema. Australian prescriber, 40(2), 59–63. https://doi.org/10.18773/austprescr.2017.012